These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 2834372)
1. A novel ganglioside, de-N-acetyl-GM3 (II3NeuNH2LacCer), acting as a strong promoter for epidermal growth factor receptor kinase and as a stimulator for cell growth. Hanai N; Dohi T; Nores GA; Hakomori S J Biol Chem; 1988 May; 263(13):6296-301. PubMed ID: 2834372 [TBL] [Abstract][Full Text] [Related]
2. Effects of gangliosides GM3 and De-N-acetyl GM3 on epidermal growth factor receptor kinase activity and cell growth. Song WX; Vacca MF; Welti R; Rintoul DA J Biol Chem; 1991 Jun; 266(16):10174-81. PubMed ID: 1645342 [TBL] [Abstract][Full Text] [Related]
3. Ganglioside-mediated modulation of cell growth. Specific effects of GM3 and lyso-GM3 in tyrosine phosphorylation of the epidermal growth factor receptor. Hanai N; Nores GA; MacLeod C; Torres-Mendez CR; Hakomori S J Biol Chem; 1988 Aug; 263(22):10915-21. PubMed ID: 2839511 [TBL] [Abstract][Full Text] [Related]
4. Ganglioside-mediated modulation of cell growth. Specific effects of GM3 on tyrosine phosphorylation of the epidermal growth factor receptor. Bremer EG; Schlessinger J; Hakomori S J Biol Chem; 1986 Feb; 261(5):2434-40. PubMed ID: 2418024 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and characterization of N-parinaroyl analogs of ganglioside GM3 and de-N-acetyl GM3. Interactions with the EGF receptor kinase. Song W; Welti R; Hafner-Strauss S; Rintoul DA Biochemistry; 1993 Aug; 32(33):8602-7. PubMed ID: 8395211 [TBL] [Abstract][Full Text] [Related]
6. Effect of lipid mimetics of GM3 and lyso-GM3 dimer on EGF receptor tyrosine kinase and EGF-induced signal transduction. Haga Y; Hatanaka K; Hakomori SI Biochim Biophys Acta; 2008 Mar; 1780(3):393-404. PubMed ID: 18036568 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of human neuroblastoma cell proliferation and EGF receptor phosphorylation by gangliosides GM1, GM3, GD1A and GT1B. Mirkin BL; Clark SH; Zhang C Cell Prolif; 2002 Apr; 35(2):105-15. PubMed ID: 11952645 [TBL] [Abstract][Full Text] [Related]
8. Ganglioside-mediated modulation of cell growth, growth factor binding, and receptor phosphorylation. Bremer EG; Hakomori S; Bowen-Pope DF; Raines E; Ross R J Biol Chem; 1984 Jun; 259(11):6818-25. PubMed ID: 6327695 [TBL] [Abstract][Full Text] [Related]
9. Modified ganglioside as a possible modulator of transmembrane signaling mechanism through growth factor receptors: a preliminary note. Hanai N; Nores G; Torres-Méndez CR; Hakomori S Biochem Biophys Res Commun; 1987 Aug; 147(1):127-34. PubMed ID: 3498483 [TBL] [Abstract][Full Text] [Related]
10. Expression of de-N-acetyl-gangliosides in human melanoma cells is induced by genistein or nocodazole. Sjoberg ER; Chammas R; Ozawa H; Kawashima I; Khoo KH; Morris HR; Dell A; Tai T; Varki A J Biol Chem; 1995 Feb; 270(7):2921-30. PubMed ID: 7852370 [TBL] [Abstract][Full Text] [Related]
12. Growth inhibition of human lung adenocarcinoma cells by antibodies against epidermal growth factor receptor and by ganglioside GM3: involvement of receptor-directed protein tyrosine phosphatase(s). Suarez Pestana E; Greiser U; Sánchez B; Fernández LE; Lage A; Perez R; Böhmer FD Br J Cancer; 1997; 75(2):213-20. PubMed ID: 9010029 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and characterization of lyso-GM3 (II3Neu5Ac Lactosyl sphingosine), de-N-acetyl-GM3 (II3NeuNH2 lactosyl Cer), and related compounds. Nores GA; Hanai N; Levery SB; Eaton HL; Salyan EK; Hakomori S Carbohydr Res; 1988 Aug; 179():393-410. PubMed ID: 3208248 [TBL] [Abstract][Full Text] [Related]
14. Lyso-GM3, its dimer, and multimer: their synthesis, and their effect on epidermal growth factor-induced receptor tyrosine kinase. Murozuka Y; Watanabe N; Hatanaka K; Hakomori SI Glycoconj J; 2007 Dec; 24(9):551-63. PubMed ID: 17638075 [TBL] [Abstract][Full Text] [Related]
15. Modulation of EGF receptor activity by changes in the GM3 content in a human epidermoid carcinoma cell line, A431. Meuillet EJ; Mania-Farnell B; George D; Inokuchi JI; Bremer EG Exp Cell Res; 2000 Apr; 256(1):74-82. PubMed ID: 10739654 [TBL] [Abstract][Full Text] [Related]
16. A role of lyso-phosphatidylcholine in GM3-dependent inhibition of epidermal growth factor receptor autophosphorylation in A431 plasma membranes. Igarashi Y; Kitamura K; Zhou QH; Hakomori S Biochem Biophys Res Commun; 1990 Oct; 172(1):77-84. PubMed ID: 2171524 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of EGF-mediated receptor activity and cell proliferation by HK1-ceramide, a stable analog of the ganglioside GM3-lactone. Alves F; Borchers U; Keim H; Fortte R; Olschimke J; Vogel WF; Halfter H; Tietze LF Glycobiology; 2002 Aug; 12(8):517-22. PubMed ID: 12145192 [TBL] [Abstract][Full Text] [Related]
18. Reconstitution of membranes simulating "glycosignaling domain" and their susceptibility to lyso-GM3. Iwabuchi K; Zhang Y; Handa K; Withers DA; Sinaÿ P; Hakomori S J Biol Chem; 2000 May; 275(20):15174-81. PubMed ID: 10809752 [TBL] [Abstract][Full Text] [Related]
19. Control of cell motility by interaction of gangliosides, tetraspanins, and epidermal growth factor receptor in A431 versus KB epidermoid tumor cells. Park SY; Yoon SJ; Freire-de-Lima L; Kim JH; Hakomori SI Carbohydr Res; 2009 Aug; 344(12):1479-86. PubMed ID: 19559406 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and characterization of ganglioside GM3 derivatives: lyso-GM3, de-N-acetyl-GM3, and other compounds. Nores GA; Hanai N; Levery SB; Eaton HL; Salyan ME; Hakomori S Methods Enzymol; 1989; 179():242-53. PubMed ID: 2622350 [No Abstract] [Full Text] [Related] [Next] [New Search]